Companies: 10,795·Total market cap: $144.5T
PHAXIAM Therapeutics S.A.

PHAXIAM Therapeutics S.A.

PHXMNASDAQHealthcare
$3.10
$-0.17(-5.20%)
Market Cap$19855280
P/E Ratio—
52W High$13.0
52W Low$2.5
Overview
股票排行：Biotechnology·Healthcare·查看全部市值排行 →

PHAXIAM Therapeutics S.A.（PHXM）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · PHXM · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-1.70phxm eps ttm · phxm earnings per shareEarnings history
PE Ratio (TTM)—phxm pe ratio ttm · phxm price to earningsPE Ratio deep dive
Revenue (TTM)0.00phxm revenue ttm · phxm annual revenueFull revenue history
Dividend Yield不分红does phxm pay dividends · phxm dividend yieldDividend history
Shares Outstanding5.1Mphxm shares outstanding · phxm floatShares outstanding history
Next EarningsTBAphxm earnings date · phxm next earningsEarnings history

探索 PHAXIAM Therapeutics S.A. 数据

phxm stock data · financials
市值$19.9Mphxm market cap · phxm valuation
分析师预测—
股息不分红does phaxiam therapeutics s.a. pay dividends · phxm dividend yield
营收—phaxiam therapeutics s.a. annual revenue · phxm revenue
盈利EPS $-4.62-4520.00%phxm earnings · phxm eps
市盈率—phxm pe ratio · phxm price to earnings

财务快照

完整财报
FY 2023Revenue$0.00
202120222023
phaxiam therapeutics s.a. revenue · phxm revenue 2023
FY 2023Net Income-$23.5M▼ 10247.14% YoY
202120222023
phaxiam therapeutics s.a. net income · phxm profit 2023
FY 2023EPS$-4.62▼ 4520.00% YoY
202120222023
phxm eps · phaxiam therapeutics s.a. earnings per share 2023
TTM:Revenue: $0.00Net Income: -$16.2MEPS: $-1.70View income statement →

股票表现

完整历史
1D+0.00%
1W+0.00%
1M-0.64%
3M-39.10%
YTD-35.42%
1Y-62.92%
5Y-95.88%

关于 PHAXIAM Therapeutics S.A.

CEOEric Soyer
IPO DateOct 26, 2017
Employees49
CountryFR
Websiteerytech.com

PHAXIAM Therapeutics S.A. is a biopharmaceutical firm dedicated to creating therapies for drug-resistant bacterial infections, operating in both France and the U.S. The company's pipeline includes ery…

BiotechnologyHealthcareNASDAQADRFR

what is phaxiam therapeutics s.a. · phxm stock overview · phaxiam therapeutics s.a. company profile · who is phaxiam therapeutics s.a. ceo · phxm NASDAQ · phaxiam therapeutics s.a. headquarters · phaxiam therapeutics s.a. business segments

关于股票概览与关键数据

PHAXIAM Therapeutics S.A.（PHXM）是 Biotechnology 行业的 Healthcare 类公司，于 Oct 26, 2017 在 NASDAQ 上市。截至最近交易日，PHXM 股价为 $3.10，市值约为 $19.9M。过去12个月累计回报 -62.92%，年初至今回报 -35.42%。

2023 财年 PHAXIAM Therapeutics S.A. 营收 —。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。

常见问题

截至最近一个交易日，PHAXIAM Therapeutics S.A.（PHXM）股价为 $3.10，在 NASDAQ 上市，52周区间为 $2.50 – $13.00。

PHXM 最新股价PHXM quote todaylive ticker 实时行情
数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议